Early diagnosis of myocardial infarction (MI) and ACS

The cardiac array combines routine with novel early cardiac markers to give a clear picture of a patient's cardiac status. It can be used in A&E settings as well as cardiac and medical wards to determine the diagnosis of MI, and assess the patient's risk of future cardiac events.

A 3-year study with over 1000 patients confirmed the cardiac biochip to be 89% sensitive for MI diagnosis shortly after a cardiac event (3-6 hours), which constitutes a 20% increase in sensitivity against troponin alone. It also has the ability of ACS profiling and, with a negative predictive value of 98% at 3-6 hours, is a perfect rule-out test for the emergency setting.

All analytes on the cardiac array can be measured simultaneously with a small patient sample using Biochip Array Technology. The Evidence analyser can run 378 cardiac tests per hour, the Evidence Investigator achieves 270 tests in two hours. The Evidence MultiStat is the analyser of choice for fast results within 20 minutes.

Cardiac biochip array

• CK-MB
• Troponin I
• Myoglobin
• CA III
• GPBB
• FABP